Healthcare commercialization and patient trust

Healthcare occupies a distinctive place in society because it involves far more than an ordinary commercial transaction.

A patient seeking treatment is often physically vulnerable, emotionally distressed, and dependent on the expertise of medical professionals and healthcare institutions.

Trust, therefore, forms the moral foundation of the relationship between patients and providers.

In Bangladesh, however, the rapid expansion of private healthcare and the growing commercialization of medical services have increasingly turned healthcare into a marketplace.

While private investment has helped expand hospitals, diagnostic centers, pharmacies, and specialized services, the growing dominance of profit-oriented practices has also raised concerns about affordability, ethics, and accountability.

The resulting decline in patient trust is not merely a matter of individual misconduct; it reflects deeper structural weaknesses in the healthcare system’s governance.

The public healthcare system has long suffered from overcrowding, inadequate resources, shortages of personnel, unequal access, and persistent management challenges. These limitations have created space for private providers to flourish.

For many middle-income and affluent citizens, private hospitals and diagnostic centers appear to offer faster access, better facilities, and greater convenience.

However, the expansion of private healthcare has not always been accompanied by equally robust systems of regulation and quality assurance.

Consequently, healthcare has increasingly become a sector in which a patient’s illness may also represent a commercial opportunity.

One visible manifestation of commercialization is the growing dependence on diagnostic tests. Medicine undoubtedly requires laboratory tests, imaging, and other diagnostic tools.

The problem arises when tests are prescribed not solely on clinical necessity but are influenced by financial incentives.

Patients frequently complain about being referred for multiple tests without a clear explanation of why they are necessary.

In a system where doctors, hospitals, diagnostic centers, and pharmaceutical companies may operate within overlapping commercial networks, conflicts of interest become a major concern.

Commercialization is also evident in the rising cost of treatment. Consultation fees, diagnostic charges, hospital admission costs, medications, and emergency services can impose a substantial financial burden on households.

Patients often enter private hospitals without knowing the full cost of treatment and later face unexpectedly high bills.

A lack of transparent pricing and standardized information deepens the perception that healthcare institutions are primarily concerned with revenue generation.

When patients believe they are being treated as customers rather than as individuals in need of care, trust inevitably weakens.

Another factor fueling mistrust is the information asymmetry between doctors and patients.

Medical professionals possess specialized knowledge, while patients generally lack the capacity to independently evaluate diagnoses, treatment plans, or prescriptions. This imbalance makes ethical behavior particularly important.

A doctor may recommend the most appropriate treatment, yet if the reasoning is not clearly communicated, patients may remain suspicious.

Brief consultation times, overcrowded facilities, and weak communication often prevent meaningful doctor-patient interaction.

The pharmaceutical dimension further complicates the issue. Concerns about aggressive marketing, brand promotion, and the influence of commercial relationships on prescribing practices continue to shape public perceptions.

Patients may suspect that certain medicines are prescribed because of promotional incentives rather than therapeutic superiority.

Whether each such suspicion is justified is less important than the broader consequence: once confidence in professional impartiality begins to erode, even legitimate medical decisions can come under doubt.

The consequences of declining trust are serious. Patients may delay seeking treatment, repeatedly “shop” for doctors, rely excessively on informal advice, or turn to unqualified providers.

They may also become more vulnerable to misinformation and unscientific remedies.

A healthcare system without trust becomes less effective, even as medical facilities and technologies improve.

Moreover, mistrust can damage the reputation of ethical doctors and responsible institutions, forcing them to operate in an environment where professional credibility is increasingly questioned.

Addressing this crisis requires more than moral appeals to individual physicians. Regulatory authorities must ensure effective licensing, regular inspections, transparent pricing, and enforceable standards for hospitals and diagnostic centers.

Clinical guidelines should be strengthened to reduce unnecessary investigations and irrational prescribing.

Hospitals should clearly communicate the expected costs of major procedures and provide clear explanations of treatment options. Mechanisms for receiving and investigating patient complaints must also be accessible, impartial, and credible.

At the same time, the public healthcare system must be improved. Commercialization thrives in part because citizens who can afford it often feel compelled to seek private alternatives.

Greater investment in public hospitals, primary care, essential medicines, and professional capacity can reduce this dependency.

Digital health records and transparent monitoring systems may also help strengthen accountability, provided they are implemented with adequate safeguards.

There is no need to eliminate private healthcare; private investment can complement public provision and expand medical capacity. The real challenge is to prevent the logic of profit from overshadowing the ethics of care.

Restoring trust will require a renewed social contract in which professional ethics, institutional accountability, affordability, and patient dignity take precedence over excessive profit.

Without such a balance, Bangladesh may continue to expand its healthcare infrastructure while losing the most essential ingredient of an effective healthcare system: the trust of the people it is meant to serve.

(The author: Former Additional Secretary to the Government, Currently Associate Professor of Public Policy, Bangladesh Institute of Governance and Management– Affiliated to the University of Dhaka)